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ALERT 
Don appropriate personal protective equipment (PPE) based on the patient’s signs and 
symptoms and indications for isolation precautions. 
 
Take steps to eliminate interruptions and distractions during medication preparation. 
 
Remember to route tubes and catheters having different purposes in different, 
standardized directions (e.g., IV lines routed toward the head; enteric lines toward the 
feet).6 
 
OVERVIEW 
Many different types of medications are delivered as continuous IV infusions in acute, 
ambulatory, long-term, home care, and critical care settings. 
 
Medication error is an important topic to consider for all who administer IV medications. These 
errors, which may have serious negative consequences, can be eliminated or kept to a minimum 
by standardizing medication nomenclature, concentration, and dosing and by implementing 
medication safety factors, such as electronic order entry, bar coding, procedures for distraction-
free medication administration, protocols for high-risk IV drugs, and the use of smart 
technologies. 
 
Smart technologies are electronic devices that perform calculations for doses and flow rates after 
information is entered and programmed by the user. These devices include computers, bedside 
monitors, and electronic infusion devices. Smart electronic infusion devices have built-in 
safeguards that identify and correct programming errors before the error reaches the patient by 
triggering an alarm when drug parameters are too high or too low. They can also detect flow 
problems, air bubbles in the tubing, and other safety concerns. 
 
The type of administration system used for a continuous IV medication depends on the age and 
acuity of the patient, the type of medication ordered, the organization’s practice, and the setting. 
Flow rate devices range from simple mechanical devices using gravity to computerized smart 
electronic infusion devices. Regardless of the type of administration system used to administer 
the continuous IV infusion, the goal is controlling the rate of flow. Whether the administration 
system is simple or complex, it should be viewed as an enhancement to patient care and not a 
substitution for nursing care. 
 
A continuous IV infusion is an infusion of medication in a solution into the venous system. 
Continuous IV infusions are often used when the medication needs to be greatly diluted, the drug 
level in the blood must be tightly controlled, or large volumes of fluids need to be infused. 
 
Drug Calculations Components 
The metric system is the universally accepted system of measurement for calculating drug 
dosages (Box 1). The components of calculating a medication dosage include:7 
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• Amount of drug to be given (G) or desired dose: the amount of medication to be administered 
over a certain length of time (e.g., lidocaine 2 mg/min) 
• Dose ordered (D): the amount of medication prescribed (e.g., 2.5 mg) 
• Strength on hand (H): the medication available (e.g., 400 mg) 
• Volume on hand (V): the amount of solution available for dilution (e.g., 400 mg/2 ml 
indicates 400 mg of medication in 2 ml of liquid volume) 
• Concentration of a drug (C): the amount of medication diluted in a volume of IV solution 
(e.g., 400 mg dopamine/250 ml) (Box 2) 
• Flow rate: the speed at which the IV fluid infuses expressed as volume over time (e.g., 20 
ml/hr) 
• Drop factor: the number of drops in the IV drip chamber that is equivalent to 1 ml 
• Length of administration (Box 3) 
• Conversion factors 
 
All units of measure used in the formula must be the same when calculations are performed. If 
they are not, the units of measure must be converted (Box 4) (Box 5). 
 
Weight-Based Drug Calculations 
Choosing which weight to use can be challenging. Distribution of specific medications across fat 
and fluid body compartments varies, affecting the therapeutic level. Much disagreement and 
inconsistency exist in the literature as to which weight to use. Thus, the organization’s practice 
should be followed regarding which of these weights to use: ideal body weight, admitting 
weight, daily weight, or dry body weight. 
 
Because most drugs are titrated to the patient’s response and a desired clinical endpoint, a 
consistent approach is using the patient’s admission weight for initial dose calculations. Titrating 
is adjusting the dose to attain the desired patient response. Weaning is gradually decreasing the 
dose when the medication is being discontinued. The clinical pharmacist should be consulted for 
patients who are obese and for medications that have potentially dangerous toxicities. 
 
Pounds to Kilograms 
Medication dosages based on weight are calculated using kilograms instead of pounds. The 
universal conversion formula is 1 kg = 2.2 lb. 
 
If the patient expresses concern regarding the accuracy of a medication, the medication should 
not be given. The concern should be explored, the practitioner notified, and the order verified. 
 
Tubing or catheter should be traced from the patient to the point of origin before connecting or 
reconnecting any device or infusion.6 Tubing should be labeled at the connection site closest to 
the patient and at the connection site closest to the source when there are different access sites or 
several bags.6 Labeling reduces the chance of misconnection, especially in circumstances where 
multiple IV lines or devices are in use. Connections should not be forced, and equipment should 
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only be used for its intended purpose.6 Forced connections or workarounds could indicate that 
the connection should not be made. 
 
EDUCATION 
• Provide developmentally and culturally appropriate education based on the desire for 
knowledge, readiness to learn, and overall neurologic and psychosocial state. 
• Provide the patient and family with an explanation of the equipment and the procedure. 
• Explain to the patient and family the indications and expected response to the medication. 
• Instruct the patient and family regarding the potential side effects and adverse reactions of 
the medication. 
• Instruct the patient and family to report signs and symptoms, including pain, burning, itching, 
or swelling at the vascular access device (VAD) exit site; dizziness; shortness of breath; 
palpitations; and chest pain. 
• Explain to the patient receiving a vesicant agent to report pain, swelling, or stiffness in the 
extremity to the nurse immediately. 
• Explain to the patient that excessive movement of the IV tubing or manipulation of the 
catheter can increase the risk of extravasation. 
• Instruct the patient to let the nurse know immediately if tubing is accidentally pulled or 
tugged so the IV catheter can be checked. 
• Discuss the progression of symptoms with the patient and family if extravasation occurs. 
• Encourage questions and answer them as they arise. 
 
ASSESSMENT AND PREPARATION 
Assessment 
1. Perform hand hygiene and don PPE as indicated for needed isolation precautions. 
2. Introduce yourself to the patient. 
3. Verify the correct patient using two identifiers. 
4. Assess the patient for medication allergies. 
5. Assess the patient for contraindications to receiving the medication and notify the 
practitioner accordingly. 
6. Obtain vital signs, hemodynamic parameters, and laboratory results, if applicable. 
7. Obtain other assessment information relevant to the medication, such as a sedation scale 
score for a sedative or a pain scale score for an analgesic. 
 
Preparation 
1. Select the most appropriate IV site to minimize the risk of extravasation and infiltration of 
the medication.4 
2. Determine which weight to use if the dosage is weight based. 
3. Verify the patient’s actual admission weight in kilograms. Reweigh the patient if 
appropriate.5 Stated, estimated, or historical weight should not be used.5 
4. Obtain the medication, check the practitioner’s order, verify the expiration date, and inspect 
the medication for particulates, discoloration, or other loss of integrity. 
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Do not use medication that is cloudy or precipitated unless such is indicated by its 
manufacturer as being safe. 
 
PROCEDURE 
1. Perform hand hygiene and don gloves and appropriate PPE based on the patient’s signs and 
symptoms and indications for isolation precautions. 
2. Verify the correct patient using two identifiers. 
3. Explain the procedure to the patient and ensure that he or she agrees to treatment. 
4. Ensure the six rights of medication safety: right medication, right dose, right time, right 
route, right patient, and right documentation. Use a bar code system or compare the 
medication administration record (MAR) to the patient’s identification band. 
5. Establish patency of the VAD before administering the medication. 
 
a. Assess and confirm peripheral VAD patency by aspirating for blood return and flushing the 
VAD using, at a minimum, a 5-ml syringe filled with preservative-free 0.9% sodium chloride 
solution.2 
b. Assess and confirm central VAD patency by aspirating for blood return and flushing the 
central VAD using, at a minimum, a 10-ml syringe filled with preservative-free 0.9% sodium 
chloride solution.2 
 
6. Remove the protective cap from the medication container. 
7. Remove the protective cap from the spike of the IV administration set tubing. 
8. Insert the administration set spike into the medication container. 
9. Hang the medication container on the IV pole. 
10. Label the container with the date and time the container was hung, any additives, and the 
nurse’s initials. 
11. Squeeze the drip chamber to fill it approximately one-half full. 
12. Attach an inline filter to the end of the administration set per the organization’s practice. 
 
Rationale: Some IV medications (e.g., amiodarone) require an inline particulate-
retentive filter for administration. 
 
13. Open the clamp on the IV administration set, allow the tubing to fill slowly, and expel air. If 
an electronic infusion device is used, purge air from the tubing according to the 
manufacturer’s recommendations. 
14. Close the clamp on the IV administration set tubing when air is expelled. 
15. Label the tubing with the date in accordance with the organization’s practice. 
 
Rationale: Some organizations label the tubing with the date the tubing was hung, 
and some organizations label the tubing with the date the tubing needs to be 
changed. 
 
16. Trace tubing or catheter from the patient to point of origin.6 
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17. Disinfect the needleless connector using vigorous mechanical scrubbing for a minimum of 5 
to 60 seconds,1 according to the organization’s practice with an appropriate disinfecting 
agent (e.g., 70% isopropyl alcohol, an iodophor such as povidone-iodine, or greater than 
0.5% chlorhexidine in alcohol solution), and allow the solution to dry.1 
 
Specific guidelines directing the appropriate technique, disinfectant, or amount of 
time required to clean various devices have not been determined.1 
 
There is moderate quality evidence to support the recommendation to apply 
mechanical friction for no less than 5 seconds.1 
 
18. Remove the protective cover from the end of the IV administration set tubing and attach the 
tubing to the VAD via the needleless connector. 
19. Determine the correct flow rate using the manual mathematical calculation method, an 
electronic device, or both methods before opening the clamp on the IV administration tubing 
or initiating an IV continuous infusion. 
 
a. Manual mathematical calculation method 
 
i. Determine the flow rate: ml/hr ÷ 60 min/hr = ml/min (Box 6). 
ii. Determine the number of drops/minute: ml/min × drops/ml = drops/min (Box 6). 
iii. Convert to the same units of measure, if applicable. 
 
b. Smart electronic infusion device method 
 
i. Refer to the manufacturer’s user guide to program the smart electronic infusion device 
accurately. 
 
Monitor the infusion for flow rate accuracy. 
 
ii. Enter the necessary information, such as the patient’s weight, drug name, concentration of 
solution, and ordered dose, into the device. 
 
Rationale: Entering the patient’s weight, drug name, concentration, and ordered 
dose ensures the patient’s safety and prevents mathematical errors or data entry 
and programming errors. 
 
Review the organization’s practice regarding medications that must be infused 
using a smart electronic infusion device. 
 
iii. Program the device to calculate the flow rate electronically. 
 
20. For high-alert medications, double-check the flow rate with another qualified person to verify 
that the order and the set rate of infusion match. 
21. Label the tubing at the connection site closest to the patient and the source.7 
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22. Discard supplies, remove PPE, and perform hand hygiene. 
23. Document the procedure in the patient’s record. 
 
MONITORING AND CARE 
1. Evaluate the patient’s response by monitoring the indicated parameters for the medication. 
 
Rationale: Medications administered by continuous infusions often have potent 
effects and potentially serious adverse effects. Most medications administered by 
continuous infusions have a quick onset of action. Frequent monitoring is 
necessary during the initiation of the infusion. 
 
Reportable conditions: Adverse reactions, hemodynamic instability, cardiac 
arrhythmias, excessive sedation, respiratory depression, pruritis, urticaria 
 
2. If the patient’s response is inadequate, titrate the dosage as ordered until the response is 
adequate. 
 
Reportable condition: Desired response not achieved with current dosage range 
 
3. Monitor the patient for adverse and allergic reactions to the medication. Recognize and 
immediately treat respiratory distress and circulatory collapse, which are signs of a severe 
anaphylactic reaction. Follow the organization’s practice for emergency response. 
4. Assess the VAD exit site for signs of phlebitis, infiltration, or extravasation routinely based 
on type of therapy, the device, and the risk factors. 
 
Reportable conditions: Extravasation of medication, IV line infiltration, phlebitis 
 
5. Change the administration sets as indicated based on the type of solution administered and 
the type of infusion (continuous vs. intermittent) and if contamination is suspected. 
 
a. Change primary and secondary continuous administration sets used to deliver fluids other 
than lipids, blood, or blood products (and any add-on devices that are part of the 
administration set) no more frequently than every 96 hours.3 
b. Change detached secondary and primary intermittent administration sets (and any add-on 
devices that are part of the administration set) 24 hours.3 
 
Rationale: Increased risk of contamination exists with an increased number of 
disconnections and reconnections.3 
 
c. Place a new sterile cap on the end of the administration set after each intermittent use.3 Do 
not attach the exposed end of the administration set to a port on the same set.3 
d. Change administration sets used to administer fat emulsions (and add-on devices that are part 
of the administration set) every 12 hours and with each new container.3 
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e. Change the administration set used to administer parenteral nutrition (and add-on devices that 
are part of the administration set) every 24 hours and with each new container.3 
f. Change dedicated administration sets used to administer propofol (Diprivan®) (and add-on 
devices that are part of the administration set) every 6 or 12 hours per the manufacturer’s 
instructions and with each new container.3 
 
Rationale: Fat emulsions promote bacterial growth and can contribute to 
infection. 
 
g. Change administration sets used for blood and blood products (and add-on devices that are 
part of the administration set) every 4 hours.3 
h. Label the tubing with the date and time of the change per the organization’s practice. 
 
EXPECTED OUTCOMES 
• Medication is administered per the six rights of medication safety. 
• Desired patient response is achieved without adverse effects. 
• VAD and exit site remain without complications. 
• Dose is titrated to achieve and maintain desired patient response. 
 
UNEXPECTED OUTCOMES 
• Medication is not administered per the six rights of medication safety. 
• Adverse effects of or reactions to the medication occur. 
• Incorrect dose of medication is administered. 
• Desired patient response is not achieved and maintained. 
• Occlusion of VAD occurs. 
• Infiltration or extravasation of medication occurs. 
 
DOCUMENTATION 
• Education 
• Drug name and concentration 
• Infusion start time 
• Infusion rate 
• Infusion stop time 
• VAD exit site assessment 
• VAD used 
• VAD patency 
• Patient’s response to the medication, including any adverse reactions 
• Unexpected outcomes and related interventions 
• Patient’s weight in kilograms per the organization’s practice 
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AACN Levels of Evidence 
• Level A - Meta-analysis of quantitative studies or metasynthesis of qualitative studies with 
results that consistently support a specific action, intervention, or treatment 
• Level B - Well-designed, controlled studies, with results that consistently support a specific 
action, intervention, or treatment 
• Level C - Qualitative studies, descriptive or correlational studies, integrative reviews, 
systematic reviews, or randomized controlled trials with inconsistent results 
• Level D - Peer-reviewed professional organizational standards with clinical studies to 
support recommendations 
• Level E - Multiple case reports, theory-based evidence from expert opinions, or peer-
reviewed professional organizational standards without clinical studies to support 
recommendations 
• Level M - Manufacturer's recommendations only 
 
SUPPLIES 
• Gloves and PPE, as indicated 
• Antiseptic 
o >0.5% chlorhexidine in alcohol solution 
o Povidone-iodine 
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o 70% isopropyl alcohol 
• Calculator  
• Smart electronic infusion device 
• IV administration set tubing 
• Prepared IV solution of medication to administer 
• Preservative-free 0.9% sodium chloride prefilled syringe(s)  
 
 
Clinical Review: Kathleen M. Stacy, PhD, RN, APRN-CNS, CCNS, FCNS 
Revised: Kathleen M. Stacy, PhD, RN, APRN-CNS, CCNS, FCNS 
Published: April 2020 
Revised: May 2020 
 
 
Box 1  Basic Drug Calculation Formulas 
Drug Dosage Determinations 
A. Ratio-Proportion Method           H:V = D:G 
Drug on hand: Volume of the drug on hand = Dose ordered: Amount to give 
 
B. Formula Method 
Amount to give (G) = Dose ordered (D)    × Volume (V) 
                  Strength on Hand (H) 
 
Several formulas can be used to calculate drug dosages. For each, the following information is 
required: Amount of drug to be given (G), dose ordered (D), strength on hand (H), and volume 
on hand (V). 
 
The two methods below can be used to answer this question: If a vial contains clindamycin 
600 mg/4 ml and the order is for 300 mg of clindamycin, what volume must be given? 
 
Formula Method 
G = D × V 
       H 
 
To answer the question, a nurse would follow these steps: 
1. G = 300 mg × 4 ml 
           600 mg 
2. G = 300 mg × 4 ml 
           600 mg 
3. G = 1200 ml 
           600 
4. G = 2 ml of clindamycin (300 mg/2 ml) 
Box 1 continued on next page 
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Box 1  Basic Drug Calculation Formulas (continued on from previous page) 
Ratio-Proportion Method 
A ratio compares two related items. Proportion is the equality of two ratios. 
H (mg):V (ml) = D (mg):G (ml) 
 
To answer the question, a nurse would use this ratio: 
600 mg:4 ml = 300 mg:G 
 
Because the product of the means (4 ml × 300 mg) equals the product of the extremes (600 mg 
× G), a nurse would follow these steps: 
1. Multiply the extremes (600 mg × G) 
2. Multiply the means (4 ml × 300 mg) 
3. 600 G = 1200 ml 
4. G = 1200 ÷ 600 
5. G = 2 ml clindamycin 
 
Box 2 Concentration of Drug 
Total amount of drug (mg) ÷ total volume of solution (ml) = concentration of the solution 
(mg/ml) 
 
Drug Concentration Determination 
Concentration may be expressed as the amount of medication per milliliter of fluid or by a 
fraction, a percentage of solution, or mass. 
 
Mg/ml 
1. Determine the concentration of drug. 
Total mg of drug ÷ total volume of solution (ml) = concentration of the solution (mg/ml) 
2. Determine the infusion rate. 
Desired amount of drug (mg/min) ÷ concentration of solution (mg/ml) = infusion rate (ml/min) 
3. Convert to ml/hr: 
ml/min × 60 min/hr = ml/hr 
 
Percentage by Mass 
A percentage solution is a measure based on parts of 100. The conversion factor is 1% solution 
= 1 gm of drug in 100 ml of solution. 
Mass of medication ÷ the mass of fluid × 100. 
 
To determine the percentage by mass of a 100-gm sodium chloride solution containing 20 gm 
of medication, the nurse would apply the formula as follows: 
1. 20 gm of medication/100 gm of solution × 100 
2. 20% 
Box 2 continued on next page 
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Box 2 Concentration of Drug (continued on from previous page) 
Percentage by Volume 
volume of medication    × 100% 
total volume of solution 
 
A 1000-ml bag of fluid contains 50 ml of medication. To determine the percentage by volume, 
the nurse would apply the formula as follows: 
1. 50 ml (volume of medication)         × 100% 
    1000 ml (total volume of solution) 
2. (50 ÷ 1000) × 100% = 5% 
(Data from Turner, M.S., Poole, S.K. (2014). Chapter 3: Pharmacology. In M. Alexander and others (Eds.), Core 
curriculum for infusion nursing (4th ed., pp. 131-162). Infusion Nurses Society. Philadelphia: Wolters Kluwer.) 
 
 
Box 3 Length of Administration and Flow Rate 
Volume to be infused (ml) ÷ milliliters/hour (ml/hr) = number of hours for infusion 
 
Length of Administration 
An infusion of D5W in 0.45% sodium chloride solution has 600 ml remaining in the 
medication container. The rate of flow is 20 drops/min, and the drop factor is 12 drops/ml. To 
determine how many hours it will take for the medication to infuse, the nurse follows these 
steps: 
 
1. Convert 600 ml to hours. 
600 ml = x drops = x min = x hours 
600 ml × x drops × x min     × x hr 
                x ml       x drops   x min 
2. Fill in the known information. 
600 ml ×  12 drops  ×  1 min       × 1 hr   =  7200 hr 
                1 ml             20 drops   60 min     1200 
3. 7200 hr  = 6 hr 
    1200 
 
Flow Rate Conversion Calculations 
ml/min to drops/min 
A patient is to receive 240 ml of medication over 30 minutes. The drop factor of the IV 
administration set is 20 drops/ml. The nurse would determine the drops/min as follows: 
1. 240 ml   ×    20 drops  =   x drops   =  4800 drops 
    30 min          1 ml             min             30 min       
2. 160 drops 
    min 
Box 3 continued on next page 
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Box 3 Length of Administration and Flow Rate (continued on from previous page) 
(mU)/min to microdrops/min 
A patient is to receive 1000 ml of D5W with 10 units of oxytocin at 10 mU/min. The drop 
factor of the IV administration set tubing is 60 microdrops/ml. The nurse would determine the 
microdrops/min as follows: 
 
1. Identify the conversion factor: 1000 mU = 1 unit (u) 
2. Change the rate of flow from mU/min to microdrops/min: 
10 mU ×   x u   ×    x ml  ×   x microdrops = microdrops 
1 min       x mU       x u        x ml                    min 
3. Identify known information: 1000 mU = 1 u, 1000 ml = 10 u, and 60 microdrops = 1 ml. 
4. Set up the equation with known information: 
10 mU × 1 u           × 1000 ml × 60 microdrops 
1 min      1000 mU      10 u          1 ml 
5. 60 microdrops 
    min 
 
D5W, 5% dextrose in water; mU, milliunits 
 
 
Box 4 Metric Conversion Factors 
WEIGHT 
1 kilogram × 1000 = 1000 grams 
1 gram × 1000 = 1000 milligrams 
1 milligram × 1000 = 1000 micrograms 
1 microgram ÷ 1000 = 0.001 milligram 
1 milligram ÷ 1000 = 0.001 gram 
1 gram ÷ 1000 = 0.001 kilogram 
 
VOLUME 
1 liter × 1000 = 1000 milliliters 
1 milliliter ÷ 1000 = 0.001 liter 
 
 
Box 5   Metric System Abbreviations 
WEIGHT VOLUME LENGTH 
Kilogram = kg Liter = L Centimeter = cm 
Gram = gm Milliliter = ml Millimeter = mm 
Milligram = mg Cubic centimeter = cc  
Microgram = mc  
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Box 6 Flow Rate Determination 
The units of measure for the flow rate may be ml/hr, ml/min, or drops/min. 
A. Flow rate/hour: 
Total volume (ml) ÷ administration time (hr) = milliliters/hour (ml/hr) 
B. Flow rate/minute: 
Milliliters/hour (ml/hr) ÷ minutes/hour (min/hr) (60) = milliliters/minute (ml/min) 
C. Drops/minute: 
Milliliters/minute (ml/min) × drop factor = drops/minute (drops/min) 
 
The three methods below can be used to answer this question: If the practitioner orders 2000 
ml of medication to infuse over 24 hours, what is the flow rate? 
 
Flow Rate Determination 
Flow rate/hr 
Total volume (ml) ÷ administration time (hr) = ml/hr 
1. 2000 ml ÷ 24 hr = 83.3 ml/hr (round to nearest whole number for gravity administration) 
2. Flow rate = 83 ml/hr 
 
Flow rate/min 
ml/hr ÷ 60 min per hr = ml/min 
1. 83 ml ÷ 60 min = 1.38 ml/min (round to nearest whole number for gravity administration) 
2. Flow rate/min = 1 ml/min 
 
Drops/min 
ml/min × drops/ml = drops/min 
If the drop factor is 15 drops/ml: 
1. 1.4 ml × 15 drops = 21 drops 
     min            ml                min 
2. 21 drops/min 
 
Hourly Rate Determination 
(Drops/min × 60 min/hr) = ml/hr 
Drop factor 
 
For an administration set with a drop factor of 15 drops/ml that is infusing a solution at a rate 
of 25 drops/min: 
1. (25 drops/min × 60 min/hr) = ml/hr 
    15 drops/ml 
2. 1500 = 100 ml/hr 
    15 
 
